Medical technology firm Senseonics Holdings, Inc. is making waves with its innovative products that aim to improve the lives of people with diabetes. The company has developed and marketed continuous glucose monitoring (CGM) systems, including Eversense, Eversense XL, and Eversense E3. These implantable CGM systems use an under-the-skin sensor, a removable and rechargeable smart transmitter, and a user-friendly app to give real-time diabetes monitoring and management for up to six months. Senseonics Holdings, Inc. provides its products to healthcare providers and patients across the United States, Europe, the Middle East, and Africa via a network of distributors and strategic fulfillment partners. The company has also collaborated with the University Hospitals Accountable Care Organization. Founded in 1996, Senseonics Holdings, Inc. is headquartered in Germantown, Maryland, and continues to lead the way in diabetes management technology.
Senseonics's ticker is SENS
The company's shares trade on the NYSE stock exchange
They are based in Germantown, Maryland
There are 51-200 employees working at Senseonics
It is senseonics.com
Senseonics is in the Healthcare sector
Senseonics is in the Medical Instruments & Supplies industry
The following five companies are Senseonics's industry peers: